4-(6-OXO-2-(TRIFLUOROMETHYL)-3,6-DIHYDROCHROMENO[7,8-D]IMIDAZOL-8-YL)BENZONITRIL E FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH MOVEMENT DISORDERS

The present invention relates to the compound 4-(6-oxo-2-(trifluoromethyl)-3,6- dihydrochromeno[7,8-d]imidazol-8- yl)benzonitrile, also known as CF3CN, for use in the treatment of diseases and conditions associated with movement disorder. La présente invention concerne le composé 4-(6-oxo-2-(trifluo...

Full description

Saved in:
Bibliographic Details
Main Authors PLOWRIGHT, Alleyn Thomas, HO, Man-Ling, PFEIFFER, Thomas
Format Patent
LanguageEnglish
French
Published 30.11.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the compound 4-(6-oxo-2-(trifluoromethyl)-3,6- dihydrochromeno[7,8-d]imidazol-8- yl)benzonitrile, also known as CF3CN, for use in the treatment of diseases and conditions associated with movement disorder. La présente invention concerne le composé 4-(6-oxo-2-(trifluorométhyl)-3,6-dihydrochroméno [7,8-d] imidazol-8-yl) benzonitrile, également connu sous le nom de CF3CN, destiné à être utilisé dans le traitement de maladies et d'états associés à un trouble du mouvement.
Bibliography:Application Number: WO2023GB51356